Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
Lung B.A.S.E.S 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Assessing Incidence and Stage of Lung Cancer Diagnosis in Subjects Ages 40-54 With a 30 Pack Year History or More Within North and South Carolina
Wake Forest University Health Sciences
1,160 participants
Jan 7, 2021
INTERVENTIONAL
Conditions
Summary
Low-dose CT Screening has been shown in two large trials in the United States (NLST) and Europe (NELSON) to increase overall survival in subjects 55 years of age and older with a strong smoking history. Unfortunately, in both North Carolina (NC) and South Carolina (SC), subjects are found to have the above referenced smoking history prior to reaching the minimum age in these studies. This study is aimed at decreasing the minimum age of screening in a high-risk population.
Eligibility
Inclusion Criteria5
- Written informed consent and HIPAA authorization for release of personal health information. NOTE: HIPAA authorization may be included in the informed consent or obtained separately.
- Age 40-54 years at the time of consent.
- A positive smoking history of greater/equal to 30 pack years and they are either currently smoking or have quit within the last 15 years.
- Ability to read and understand the English and/or Spanish language.
- Ability to understand and comply with study procedures for the entire length of the study.
Exclusion Criteria4
- Subjects meeting any of the criteria below may not participate in the study:
- Known diagnosis of lung cancer in the past 5 years.
- Any known contraindication to having a low-dose CT Scan.
- Known pregnancy.
Interventions
Low Dose CT Scan of the Chest
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04577599